These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29517661)

  • 21. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microwave ablation with or without resection for colorectal liver metastases.
    Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
    Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Karagkounis G; McIntyre SM; Wang T; Chou JF; Nasar N; Gonen M; Balachandran VP; Wei AC; Soares KC; Drebin JA; D'Angelica MI; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2023 Oct; 30(11):6571-6578. PubMed ID: 37365414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of CD133
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
    Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center.
    Qin S; Liu GJ; Huang M; Huang J; Luo Y; Wen Y; Wang Y; Chen L
    Int J Hyperthermia; 2019; 36(1):36-43. PubMed ID: 30489175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting ablation site recurrence following percutaneous microwave ablation of colorectal hepatic metastases.
    Urbonas T; Anderson EM; Gordon-Weeks AN; Kabir SI; Soonawalla Z; Silva MA; Gleeson FV; Reddy S
    HPB (Oxford); 2019 Sep; 21(9):1175-1184. PubMed ID: 30777696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
    Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis.
    de Jong MC; van Vledder MG; Ribero D; Hubert C; Gigot JF; Choti MA; Schulick RD; Capussotti L; Dejong CH; Pawlik TM
    J Gastrointest Surg; 2011 Feb; 15(2):336-44. PubMed ID: 21108017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience.
    Sparchez Z; Mocan T; Hajjar NA; Bartos A; Hagiu C; Matei D; Craciun R; Mocan LP; Sparchez M; Leucuta DC
    Med Ultrason; 2019 Aug; 21(3):217-224. PubMed ID: 31476199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Carcinoembryonic Antigen Levels Before the First Curative Hepatectomy for Metastatic Colorectal Cancer Is a Predictor of Recurrence.
    Kawahara H; Yoshida S; Tohyama Y; Yanagisawa S; Misawa T; Yanaga K
    Anticancer Res; 2018 Sep; 38(9):5351-5355. PubMed ID: 30194188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study.
    Shi Q; Wang F; Du N; Zhou Y; Zhou X; Ma J; Yang M; Zhang Z; Yu J; Zhang W; Luo J; Liu L; Yan Z
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101986. PubMed ID: 35772684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the Postoperative Carcinoembryonic Antigen Level during Follow-Up after Curative Resection in Patients with Liver Metastatic Colorectal Carcinoma.
    Hashimoto T; Itabashi M; Ogawa S; Hirosawa T; Bamba Y; Kaji S; Ubukata M; Shimizu S; Sugihara K; Kameoka S
    Hepatogastroenterology; 2014 Jun; 61(132):989-93. PubMed ID: 26158154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of ultrasound-guided percutaneous microwave ablation and surgical resection for colorectal cancer with liver metastasis].
    Huang Z; Li KY; Zhou PP; Wu XB; Li SS
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):696-701. PubMed ID: 32187914
    [No Abstract]   [Full Text] [Related]  

  • 36. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
    Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
    Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent.
    Gunawardene A; Larsen P; Shekouh A; Dennett E
    ANZ J Surg; 2018 Dec; 88(12):1311-1315. PubMed ID: 30066426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
    Hohenberger P; Schlag PM; Gerneth T; Herfarth C
    Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
    J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
    Odisio BC; Yamashita S; Huang SY; Kopetz SE; Ahrar K; Mizuno T; Conrad C; Aloia TA; Chun YS; Gupta S; Vauthey JN
    J Vasc Interv Radiol; 2018 Mar; 29(3):395-403.e1. PubMed ID: 29395898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.